PL409330A1 - Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA - Google Patents
Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNAInfo
- Publication number
- PL409330A1 PL409330A1 PL409330A PL40933014A PL409330A1 PL 409330 A1 PL409330 A1 PL 409330A1 PL 409330 A PL409330 A PL 409330A PL 40933014 A PL40933014 A PL 40933014A PL 409330 A1 PL409330 A1 PL 409330A1
- Authority
- PL
- Poland
- Prior art keywords
- staphylococcus aureus
- production
- plasmid dna
- deprived
- impurities
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/44—Staphylococcus
- C12R2001/445—Staphylococcus aureus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Ujawniono szczepy Staphylococcus aureus do otrzymywania monoklonalnych preparatów bakteriofagów litycznych o wysokim mianie, pozbawionych zanieczyszczeń niepożądanymi bakteriofagami oraz plazmidowym DNA, które gwarantują produkcję bezpiecznych w stosowaniu preparatów bakteriofagowych nie będących źródłem rozsiewu genów związanych z wirulencją bakterii. Korzystnie jest to szczep Staphylococcus aureus 80wphwpl zdeponowany w PCM jako B/00072 albo szczep Staphylococcus aureus 6409wphpl zdeponowany w PCM jako B/00073.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409330A PL236568B1 (pl) | 2014-08-31 | 2014-08-31 | Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
EP15797403.1A EP3186362B1 (en) | 2014-08-31 | 2015-08-31 | Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna |
EP18195142.7A EP3460048B1 (en) | 2014-08-31 | 2015-08-31 | Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna |
PCT/IB2015/056606 WO2016030871A1 (en) | 2014-08-31 | 2015-08-31 | Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna |
PL18195142T PL3460048T3 (pl) | 2014-08-31 | 2015-08-31 | Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL409330A PL236568B1 (pl) | 2014-08-31 | 2014-08-31 | Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
Publications (2)
Publication Number | Publication Date |
---|---|
PL409330A1 true PL409330A1 (pl) | 2016-03-14 |
PL236568B1 PL236568B1 (pl) | 2021-01-25 |
Family
ID=54601839
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL409330A PL236568B1 (pl) | 2014-08-31 | 2014-08-31 | Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
PL18195142T PL3460048T3 (pl) | 2014-08-31 | 2015-08-31 | Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL18195142T PL3460048T3 (pl) | 2014-08-31 | 2015-08-31 | Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP3460048B1 (pl) |
PL (2) | PL236568B1 (pl) |
WO (1) | WO2016030871A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6670106B2 (ja) * | 2012-04-26 | 2020-03-18 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | ブドウ球菌コアグラーゼ抗原およびその使用方法 |
WO2019152657A1 (en) | 2018-02-03 | 2019-08-08 | Simple Healthkit, Inc. | Reliable, comprehensive, and rapid sexual health assessment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2012668A3 (cs) * | 2012-09-27 | 2013-08-07 | Imuna S.R.O. | Lécivo ve forme antistafylokokového fágového lyzátu, zpusob jeho výroby a pouzití |
-
2014
- 2014-08-31 PL PL409330A patent/PL236568B1/pl unknown
-
2015
- 2015-08-31 EP EP18195142.7A patent/EP3460048B1/en active Active
- 2015-08-31 EP EP15797403.1A patent/EP3186362B1/en active Active
- 2015-08-31 WO PCT/IB2015/056606 patent/WO2016030871A1/en active Application Filing
- 2015-08-31 PL PL18195142T patent/PL3460048T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
PL3460048T3 (pl) | 2021-10-25 |
EP3460048B1 (en) | 2021-04-28 |
WO2016030871A1 (en) | 2016-03-03 |
EP3186362A1 (en) | 2017-07-05 |
EP3460048A1 (en) | 2019-03-27 |
PL236568B1 (pl) | 2021-01-25 |
EP3186362B1 (en) | 2019-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022000056A (es) | Peptidos anti-microbianos estabilizados. | |
PH12016502555A1 (en) | Methods of preparing substituted nucleotide analogs | |
MX2022001105A (es) | Anticuerpos anti tigit. | |
EA201891202A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
MX2017008184A (es) | Nucleosidos sustituidos, nucleotidos y analogos de estos. | |
EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
MY188541A (en) | Besifloxacin for the treatment of resistant acne | |
EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
MY176328A (en) | Targeted mutations | |
WO2015153889A3 (en) | Materials and methods for the treatment of latent viral infection | |
WO2016033439A3 (en) | Compositions and methods for the treating an inflammatory disease or disorder | |
EA201790265A1 (ru) | Способы получения тромбоцит-содержащих продуктов | |
PH12018500379A1 (en) | Biopharmaceutical compositions | |
PH12016501968A1 (en) | Novel macrocyclic compounds | |
MX2017015462A (es) | Vectores atenuados de influenza para la prevencion y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncologicas. | |
PL409332A1 (pl) | Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych | |
MX2018005872A (es) | Profarmacos de acido nucleico. | |
MX2017016401A (es) | Composiciones inmunogenas. | |
WO2016100615A3 (en) | Methods and composition for neutralization of influenza | |
PL409330A1 (pl) | Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA | |
MX2019005535A (es) | Streptococcus thermophilus para uso en la preparación de productos fermentados. | |
PL434248A1 (pl) | Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA | |
PL434249A1 (pl) | Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych | |
MX2017011648A (es) | Metodos de piolisina y composiciones. |